Sign up to save your podcasts
Or
Share The Defense Tech Unicorn Tracking Biological Threats
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Defense Tech Unicorn Tracking Biological Threats
CEO Matt McKnight joins Exiger Exchange to talk about the next frontier of national security: biology.
He is a Marine Corps veteran, and former CCO of the now publicly-traded Gingko Bioworks. Matt's new business is a unicorn called Perimeter, a company focused on defending against biological threats. In this episode, we discuss why biosecurity is starting to look a lot like cybersecurity did in the 1990s - an untapped market, misunderstood, and about to become essential.
Matt explains how advances in AI and bioengineering are changing the risk landscape, why governments and companies need “bio threat radar,” and how biological intelligence could become a critical input for supply chain resilience, public health, and national defense.
We also cover China’s biotech ambitions, the reshoring of critical medicine supply chains, and why the future of national security may depend on how quickly we can detect, attribute, and respond to biological risk.
View all episodes
By Kit ConklinCEO Matt McKnight joins Exiger Exchange to talk about the next frontier of national security: biology.
He is a Marine Corps veteran, and former CCO of the now publicly-traded Gingko Bioworks. Matt's new business is a unicorn called Perimeter, a company focused on defending against biological threats. In this episode, we discuss why biosecurity is starting to look a lot like cybersecurity did in the 1990s - an untapped market, misunderstood, and about to become essential.
Matt explains how advances in AI and bioengineering are changing the risk landscape, why governments and companies need “bio threat radar,” and how biological intelligence could become a critical input for supply chain resilience, public health, and national defense.
We also cover China’s biotech ambitions, the reshoring of critical medicine supply chains, and why the future of national security may depend on how quickly we can detect, attribute, and respond to biological risk.